Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India

Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India

Approximately three per cent of the world's population (170-200 million people) is chronically infected with hepatitis C virus (HCV) and almost 500,000 people die each year (mostly in lower middle-income countries) from complications secondary to HCV infection. In India, HCV infection imposes a...

Full description

Bibliographic Details
Main Authors: Varun Gupta, Ashish Kumar, Praveen Sharma, Anil Arora
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Medical Research
Subjects:
Antiviral therapy - chronic hepatitis - cirrhosis - direct-acting antivirals - hepatitis C virus - hepatocellular carcinoma - sofosbuvir
Online Access:http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2017;volume=146;issue=1;spage=23;epage=33;aulast=Gupta

Internet

http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2017;volume=146;issue=1;spage=23;epage=33;aulast=Gupta

Similar Items